Healthcare news and intelligence for Southern Africa
Daily reporting for the pharmaceutical, medical scheme and hospital sectors, published by Health Matters since 1994.
8 October 2026
Cancer in South Africa is rising, with deaths forecast to nearly double by 2050. Learn what ageing, smoking and urbanisation mean for care.
Latest
8 October 2026
8 October 2026
6 October 2026
6 October 2026
5 October 2026
More news
5 July 2024
Following a Constitutional Court ruling, Clicks Group plans to sell its shareholding in Unicorn Pharmaceuticals, enabling new pharmacy license applications.
5 July 2024
Experts warn of gaps in bird flu surveillance, highlighting risks of a potential pandemic. Comprehensive monitoring and early detection are crucial.
5 July 2024
An HIV prevention injection that provides six months of protection per shot is highly effective in a pivotal trial largely conducted in South Africa.
5 July 2024
Aaron Mostsoaledi has been reappointed as Health Minister in the Government of National Unity, with Joe Phaahla appointed as his deputy.
5 July 2024
Life Healthcare's subsidiary, Life Molecular Imaging, has sub-licensed its radiotherapeutic products to Lantheus Holdings for $35 million.
5 July 2024
India will incentivise local GLP-1 drug manufacturing by 2026, targeting diabetes and obesity treatments, as Novo Nordisk's patent expires.
28 June 2024
The chance of a miscarriage or stillbirth can be up to 8% higher during floods or long periods of heat than in normal times.
28 June 2024
In the beleaguered public health sector cutting-edge surgical robots have been used to perform more than 600 surgeries at two Cape Town public hospitals.
26 June 2024
The FDA's draft guidance aims to improve diversity in clinical trials by encouraging manufacturers to set enrolment goals based on age, ethnicity, sex, and race.
26 June 2024
GLP-1 receptor agonists, initially for diabetes and weight loss, show promise in substance addiction treatment. A transformative breakthrough in healthcare.
26 June 2024
The South African Border Management Authority has activated its Mpox preparedness plan, implementing robust screening at all ports of entry.
26 June 2024
Early results from the PURPOSE 1 trial show that an injectable antiretroviral drug can prevent HIV infection in cisgender women, marking a historic breakthrough.
The archive
Browse every Health Matters article by month.